Cargando…
Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells
Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed MCL. Molecular mechanisms of fludarabine resistance...
Autores principales: | Lorkova, Lucie, Scigelova, Michaela, Arrey, Tabiwang Ndipanquang, Vit, Ondrej, Pospisilova, Jana, Doktorova, Eliska, Klanova, Magdalena, Alam, Mahmudul, Vockova, Petra, Maswabi, Bokang, Klener, Pavel, Petrak, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540412/ https://www.ncbi.nlm.nih.gov/pubmed/26285204 http://dx.doi.org/10.1371/journal.pone.0135314 |
Ejemplares similares
-
Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents
por: Klanova, Magdalena, et al.
Publicado: (2014) -
Proteomic and transcriptomic analysis of heart failure due to volume overload in a rat aorto-caval fistula model provides support for new potential therapeutic targets - monoamine oxidase A and transglutaminase 2
por: Petrak, Jiri, et al.
Publicado: (2011) -
Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma
por: Klener, Pavel
Publicado: (2019) -
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
por: Obr, Ales, et al.
Publicado: (2022) -
BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
por: Klanova, Magdalena, et al.
Publicado: (2020)